Indaptus Therapeutics Inc (INDP)
0.5295 -0.0204 (-3.71%) 12:12 ET [NASDAQ]
0.5220 x 6 0.5370 x 155
Realtime by (Cboe BZX)
0.5220 x 6 0.5370 x 155
Realtime 0.5500 +0.0001 (-) 08:00 ET
for Mon, Mar 31st, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 5,787 | 7,381 | 7,302 | 9,742 | 13,362 |
TOTAL | $6,618 | $7,629 | $7,489 | $10,293 | $13,995 |
Non-Current Assets | |||||
PPE Net | N/A | N/A | N/A | N/A | 1 |
Other Non-Current Assets | 720 | 610 | 633 | 656 | 928 |
TOTAL | $720 | $610 | $633 | $656 | $929 |
Total Assets | $7,339 | $8,240 | $8,122 | $10,949 | $14,924 |
Liabilities | |||||
Current Liabilities | |||||
Accounts payable and accrued liabilities | 3,310 | 2,129 | 1,825 | 1,435 | 2,672 |
TOTAL | $3,394 | $2,233 | $1,928 | $1,537 | $2,774 |
Non-Current Liabilities | |||||
aiOther Non-Current Liabilities | 0 | 4 | 28 | 51 | 73 |
TOTAL | $N/A | $4 | $28 | $51 | $73 |
Total Liabilities | $3,394 | $2,237 | $1,956 | $1,588 | $2,847 |
Shareholders' Equity | |||||
Shares Outstanding, K | 14,429 | 10,197 | 10,197 | 8,539 | 8,539 |
Common Shares | 120 | 102 | 86 | 85 | 84 |
Retained earnings | -60,439 | -56,308 | -53,239 | -49,224 | -45,417 |
TOTAL | $3,945 | $6,003 | $6,166 | $9,361 | $12,077 |
Total Liabilities And Equity | $7,339 | $8,240 | $8,122 | $10,949 | $14,924 |